Cardiovascular risk factors in the Maghreb. A systematic review.


Journal

La Tunisie medicale
ISSN: 2724-7031
Titre abrégé: Tunis Med
Pays: Tunisia
ID NLM: 0413766

Informations de publication

Date de publication:
Jan 2021
Historique:
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 29 10 2021
Statut: ppublish

Résumé

To assess the distribution of cardiovascular risk factors in Maghreb's countries. It is a systematic review including articles and reports that applied the WHO "STEPwise" approach, or a similar approach, studying cardiovascular risk factors in the Maghreb countries: Tunisia, Morocco, Algeria, Libya and Mauritania between 2004 and 2018. We selected five articles, a report for each country. The prevalence of smoking was between 13.4% (12.2-14.6) in Morocco and 29.4% (28.3-30.4%) in Tunisia. 50.6% of the population of Mauritania had insufficient physical activity. The prevalence of high blood pressure was highest in Libya (40.6%) The prevalence of obesity was up to 41.1% (37-43.3) for women and 21.4% (19-23.8) in men in Libya. The prevalence of diabetes mellitus was between 10.6% (9.7-11.6) in Morocco and 16.4% (14.7-19.1) in Libya. The distribution of cardiovascular risk factors in the Maghreb countries shows that the level of cardiovascular risk is high, particularly in the central Maghreb. This attests to the fairly advanced epidemiological transition related to the rapid modernization of the Arab countries, hence the importance of launching an integrated project for the fight against cardiovascular diseases based on the global experience.

Identifiants

pubmed: 33899179
pii: /article-medicale-tunisie.php?article=3837
pmc: PMC8636961

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-128

Références

Circulation. 2001 Nov 27;104(22):2746-53
pubmed: 11723030
Ann Nutr Metab. 2010;57(3-4):193-203
pubmed: 21088386
Circ Res. 2017 Sep 1;121(6):677-694
pubmed: 28860318
Bull World Health Organ. 2008 May;86(5):322-2A
pubmed: 18545727
Int J Public Health. 2015 Jan;60 Suppl 1:S3-11
pubmed: 25280526
BMJ Open. 2016 Nov 30;6(11):e009195
pubmed: 27903556
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Am J Prev Med. 2011 Jul;41(1):52-60
pubmed: 21665063
PLoS One. 2013 Apr 09;8(4):e60594
pubmed: 23593257
Tunis Med. 2018 Oct-Nov;96(10-11):545-556
pubmed: 30746647

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH